top of page
Contact Us
Contact Us
Careers

More case studies

Ensuring batch-consistent, compliant comparator supply across NA, EU, and APAC - on time and uninterrupted.

Read all

Effective Sourcing of Semaglutide for a Global Phase III Clinical Trial

Adaptive, multi-product supply across 22 countries and 80 sites, kept on time, in budget and compliant.

Read all

CSI’s Expert Delivery of a Global Respiratory Study

A leading global biopharmaceutical company urgently requested CSI to supply the Fluarix QIV Southern Hemisphere Vaccine for 2025.

Read all

Rapid Sourcing of Discontinued Southern Hemisphere Vaccine for a Global Biopharmaceutical Client

Securing reliable, cost-effective, long-term supply of Eylea PFS from EU and USA for a global biotech company’s clinical studies.

Read all

Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies

A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial.

Read all

Comparator Sourcing for a Phase II Ophthalmology Study

CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries

Read all

How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time

Export of expensive comparators from Europe to China with first leg documents and streamlined approach

Read all

CSI’s seamless comparator export to China

CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay

Read all

Global Device Distribution

How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market

Read all

Rescuing a Global Biotech's Oncology Study with Cetuximab

How CSI fulfilled what our competitors couldn’t: rapidly sourcing oncology medication from the EU for a trial in South Korea

Read all

Rescuing a Biotech’s Oncology Trial with Lenvima

How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price

Read all

Delivering €1 million Savings for Pembrolizumab

How CSI supplied large quantities of Jakavi to a Biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67 site shipments

Read all

Global Jakavi Study

Challange

A global sponsor urgently required 450 packs of Abraxane (nab-paclitaxel) for multiple European sites after the original supplier fell short. The request came with tight lead times, limited local availability, and strict quality/regulatory constraints: a single-batch requirement for consistency and a Certificate of Analysis (CoA) for release. Any delay risked site activation and FPFV slippage across the study.

Solution

CSI mobilised a rapid, end-to-end contingency plan to secure and deliver compliant supply inside 72 hours:


  • Direct sourcing & batch lock: Leveraged manufacturer relationships to confirm one compliant batch and the full 450-pack quantity.

  • Regulatory & QP coordination: Prepared the necessary documentation and coordinated QP release to meet EU requirements and maintain audit readiness.

  • Cold-chain logistics: Arranged temperature-controlled transport to European depots with tight hand-offs to keep timelines intact.

  • Cross-site alignment: Sequenced shipments for rapid allocation across sites so activation could proceed without stock-related holds.

  • Operational transparency: Provided clear status updates and documentation packs to the sponsor and CRO to accelerate local approvals and depot receipt.

  • Issue escalation path: Stood up a 24/7 contact for customs or lane disruptions, with predefined alternates to avoid last-mile delays.

Result

CSI delivered the full 450 packs ahead of the internal deadline, preserving FPFV and preventing activation delays. The sponsor highlighted CSI’s speed, transparency, and compliance discipline—achieving 100% batch consistency with CoA provided and uninterrupted dosing at sites.

Case Study

CSI's 72-hour Abraxane Rescue Mission

From supply shortfall to on-time first-patient-first-visit across Europe, delivered in three days.

Challange

Sponsor needed 450 packs of Abraxane across multiple EU sites on an urgent timeline, requiring one batch with CoA—risking delays to FPFV.

Solution

CSI activated contingency sourcing, secured a single batch, completed regulatory/QP steps, and arranged temperature-controlled distribution—within 72 hours.

Result

Full quantity delivered ahead of the study timeline; no site activation delays; dosing stayed on track

Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements

Contact us 

bottom of page